Should I consider Ipsen?

Quote

Should I consider Ipsen?

  • yes

    Votes: 0 0.0%

  • RUN!

    Votes: 0 0.0%
  • Total voters
    0

Ipsen is a constantly changing company which is good and bad.

IC is a huge issue and numbers are unreliable. There are many divisions of Ipsen that get by doing absolutely nothing.

in the field contracts are more important than performance, your success can be in someone else’s hands too often.

the good part is the work life balance, with very few exceptions you won’t be hounded about your numbers.

Ipsen is a flawed company that knows it’s flawed, it’s a bit of an unspoken agreement.
 
anonymous said:
Ipsen is a constantly changing company which is good and bad.

IC is a huge issue and numbers are unreliable. There are many divisions of Ipsen that get by doing absolutely nothing.

in the field contracts are more important than performance, your success can be in someone else’s hands too often.

the good part is the work life balance, with very few exceptions you won’t be hounded about your numbers.

Ipsen is a flawed company that knows it’s flawed, it’s a bit of an unspoken agreement.
Click to expand...
 
big pharma indeed, just like goal setting. Some areas have great managed care access yet are asked to grow the exact same amount as a challenging area. One size fits all. Just a reflection of the people who are in IC are braindead and wonder why the company can't keep people very long.
 
If you come here I hope your experience is better than my own and others I know within Ipsen. So far I've witnessed a high level of disregard for patient care and it all being about money vs helping people suffering from some devastating conditions. In about 2 years most people here see the cracks in the foundation and start their exit plan. It's a job and count it as such. This company gets in its own way of being successful.
 
anonymous said:
If you come here I hope your experience is better than my own and others I know within Ipsen. So far I've witnessed a high level of disregard for patient care and it all being about money vs helping people suffering from some devastating conditions. In about 2 years most people here see the cracks in the foundation and start their exit plan. It's a job and count it as such. This company gets in its own way of being successful.
Click to expand...


How so? This hasn’t been my experience beyond stupid pricing.

Ipsen is very engaged with patient communities. If there is an issue it’s that Medical Affairs isn’t as involved as it should be.
 
anonymous said:
ipsen. Do well, then spend your days chasing excessive goals in a disease the leadership has no idea how to forecast. It’s horrible
Click to expand...
management is overbearing here. That’s one reason why there is so much turnover. People are miserable. The only good thing is so many people are getting new jobs and double dipping before giving there resignation, so cashing in some money during covid=19.
 
Ipsen is a shell of what it was and rapidly becoming a sewer of failure. It's one misstep and lack of vision after the other for past couple years. This is not the oncology company I signed up for and never will be. Lots of promises made - few kept in clinical development.
 
anonymous said:
Ipsen is a shell of what it was and rapidly becoming a sewer of failure. It's one misstep and lack of vision after the other for past couple years. This is not the oncology company I signed up for and never will be. Lots of promises made - few kept in clinical development.
Click to expand...

When all the best science minds are ejecting from the Oncology Space- you know the future is not good here at IPSEN. Trials are garbage and future is trash. Run!
 
anonymous said:
Neuro is beyond awful. New VP knows nothing. Treats reps like little kids. Continues to make bad decisions. Everyone is miserable here!! RUN.
Click to expand...

I completely disagree about the new VP in Neuro. My experience is that she has been standing up for her people and works tirelessly to create an positive, open and collaborative culture. Things are changing, as it should with a new VP, but I believe her intentions are good. If you think Neuro is awful, you really don't know the hard working people I know - you may want to look in the mirror because you will likely find what has made it awful for you. I wish you luck and much happiness - somewhere else.
 
anonymous said:
Ipsen is a constantly changing company which is good and bad.

IC is a huge issue and numbers are unreliable. There are many divisions of Ipsen that get by doing absolutely nothing.

in the field contracts are more important than performance, your success can be in someone else’s hands too often.

the good part is the work life balance, with very few exceptions you won’t be hounded about your numbers.

Ipsen is a flawed company that knows it’s flawed, it’s a bit of an unspoken agreement.
Click to expand...
 
Oncology drugs not going anywhere fast. One will have several generic versions in next year or two, and the other will probably not move up the line in treatment sequencing anytime soon. Some management very good, and on the other hand some is not very good at all. Heard mid-south manager still thinks it's 1999 Pfizer days, and no accountability for his 'management' style.
 


Write your reply...
Top Bottom
Back
Quote